I am senior research scientist at Inria, and team leader at the Paris Brain Institute (ICM) located at the Pitié-Salpêtrière hospital in Paris. I am fellow of the Paris AI Research Institute (PR[AI]RIE). Since 2022, I am co-founder and CEO of Qairnel, a spin-off company dedicated to making precision neurology available to everyone.
My research lies at the intersection of statistical learning and differential geometry with applications in neuroscience and clinical trial designs. We develop statistical methods for the analysis of structured data such as images or meshes. In particular, we invented the technique named "disease course mapping" for the analysis of longitudinal data, e.g. repeated data of the same subjects over time. This technique allowed the construction of personalised models of disease progression for several neurodegenerative diseases: Alzheimer, Parkinson or Huntington. These models are used to spot the optimal moment to test new therapies in each patient.
I received several awards including the MICCAI Young Investigator Award in 2008, the second Gilles Kahn Award for best dissertation in computer science in 2010. In 2015, I was awarded an ERC Starting Grant from the European Research Council. I was the first laureate of a Sanofi iDEA award outside the USA in 2019. In 2020, I received the Inria - Académie des Sciences young researcher award.